Published Online
on February 1, 2007

A more recent version of this article appeared on March 1, 2007

This Article Full Text (PDF) All Versions of this Article: 38/3/1113    most recent 01.STR.0000258356.68323.6dv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciccone, A. Articles by Santilli, I. Search for Related Content PubMed PubMed Citation Articles by Ciccone, A. Articles by Santilli, I. Related Collections Fibrinogen/fibrin Acute Cerebral Infarction Antiplatelets Platelets

Submitted on September 27, 2006
Accepted on October 2, 2006

Glycoprotein IIb-IIIa Inhibitors for Acute Ischemic Stroke

Alfonso Ciccone MD^*; Iosief Abraha MD; and Ignazio Santilli MD

From the Stroke Unit, "Niguarda Ca’ Granda" Hospital (A.C., I.S.), Milan, Italy; and the Epidemiology Department (I.A.), Regional Health Authority of Umbria, Perugia.

^* To whom correspondence should be addressed. E-mail: alfonso.ciccone{at}ospedaleniguarda.it.

Key words: acute stroke • antiplatelet agents • antiplatelet drugs • brain infarction • brain ischemia • cerebral infarct • cerebrovascular accident • platelet inhibitors • randomized controlled trials • stroke management • therapy • thrombosis • glycoprotein IIb-IIIa inhibitors • meta-analysis • systematic review

This article has been cited by other articles:

				C. Kleinschnitz, M. Pozgajova, M. Pham, M. Bendszus, B. Nieswandt, and G. Stoll Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding Circulation, May 1, 2007; 115(17): 2323 - 2330. [Abstract] [Full Text] [PDF]